Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07917832 | Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma | ||
| NCT05327270 | Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions | ||
| NCT07011654 | Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) | ||
| NCT02057445 | 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma | ||
| NCT00527761 | Taxotere/Temodar/Cisplatin Study in Melanoma Patients | ||
| NCT00050986 | Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme | ||
| NCT04604522 | Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome | ||
| NCT00883688 | Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma | ||
| NCT01750983 | Ipilimumab and Lenalidomide in Advanced Cancer | ||
| NCT00413166 | All-trans Retinoic Acid, and Arsenic +/- Idarubicin | ||
| NCT02160366 | Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients | ||
| NCT00423722 | Parenteral Hydration in Advanced Cancer Patients | ||
| NCT05046080 | Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix | ||
| NCT05273554 | A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma | ||
| NCT03199196 | Using Social Networks to Promote Physical Activity in African American and Hispanic Women | ||
| NCT02060370 | Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) | ||
| NCT00426829 | Proton Therapy and Bevacizumab for Primary Liver Tumors | ||
| NCT00671827 | Evaluation of Robot-Assisted Surgery in Gynecologic Oncology | ||
| NCT00215202 | Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) | ||
| NCT05744557 | Vapocoolant Analgesia for Breast Lymphoscintigraphy | ||
| NCT02511600 | Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication | ||
| NCT05041153 | Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma | ||
| NCT06218602 | Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. | ||
| NCT06563375 | Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors | ||
| NCT00610181 | Magnetic Resonance Imaging in Patients With Breast Cancer | ||
| NCT02203136 | Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging | ||
| NCT00878267 | Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study | ||
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | ||
| NCT00493571 | Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes | ||
| NCT06597734 | A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm | ||
| NCT00806507 | Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients | ||
| NCT07318363 | IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention | ||
| NCT04668300 | Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma | ||
| NCT03287492 | RCT of QPS vs General Information Sheet | ||
| NCT00038792 | Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD | ||
| NCT05091632 | Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit | ||
| NCT00792077 | A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue | ||
| NCT04983901 | PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | ||
| NCT05048212 | A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases | ||
| NCT04904302 | Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer | ||
| NCT05589857 | A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use | ||
| NCT01811628 | Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers | ||
| NCT00423436 | Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT02029612 | An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy) | ||
| NCT00505492 | Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | ||
| NCT01008787 | Motivational Interviewing for Physical Activity | ||
| NCT01504919 | Reducing Cancer Disparities Among Latinos in Texas | ||
| NCT02389309 | Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors | ||
| NCT07023432 | Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC) | ||
| NCT00270907 | CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer |
